Possible role of arginase-1 in concomitant tumor immunity.
The expression of Adenovirus serotype 2 or serotype 5 (Ad2/5) E1A in tumor cells reduces their tumorigenicity in vivo by enhancing the NK cell mediated and T cell mediated anti-tumor immune response, an activity that correlates with the ability of E1A to bind p300. We determined if E1A could be used...
Main Authors: | Michael J Korrer, Yuwen Zhang, John M Routes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3948845?pdf=render |
Similar Items
-
Correction: Possible Role of Arginase-1 in Concomitant Tumor Immunity.
by: Michael J Korrer, et al.
Published: (2016-01-01) -
The in vivo & in ritro effects of arginase on murine immunity & on tumor growth
by: Hou, Fang-Yue, et al. -
The in vivo & in ritro effects of arginase on murine immunity & on tumor growth
by: HOU, FANG-YAO, et al.
Published: (1987) -
Frequent adaptive immune responses against arginase-1
by: Evelina Martinenaite, et al.
Published: (2018-03-01) -
Concomitant type I IFN and M-CSF signaling reprograms monocyte differentiation and drives pro-tumoral arginase productionResearch in context
by: Yuanyuan Tong, et al.
Published: (2019-01-01)